Researchers pooled ten studies and saw no clear rise in miscarriage or birth defects. They say this offers limited reassurance and does not show the drugs are safe in pregnancy.
Recap by typeshit. Full story at EMJ.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
A Williamsburg shop sells injectable peptide vials for around $95 each, while the FDA has sent warning letters to sellers relying on the same label.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
UW Medicine notes that many of these experimental peptides have not been regulated by the FDA, and some have never been tested in people.
An Emory-linked abstract shown in Nashville found the link in past records. The authors say it isn't peer reviewed and patients shouldn't change medication over it.
The Vancouver firm says its patch aims to skip needles and refrigeration, and it plans a further update once testing results are in. No outcome data yet.
Loading…